Table 1 Evaluation of carcinogenic risks to humans by the International Agency for Research on Cancer
From: Exposure to environmental chemicals and cancer risk: epidemiological evidence from Japanese studies
Agent | Overall evaluation | Tumour sites (or types) for which there is sufficient evidence in humans | Other sites with limited evidence in humans |
|---|---|---|---|
Dichlorodiphenyltrichloroethane | Group 2A | Â | Liver, testis, non-Hodgkin lymphoma |
Lindane, the γ-isomer of hexachlorocyclohexane | Group 1 | Non-Hodgkin lymphoma |  |
Polychlorinated biphenyls | Group 1 | Malignant melanoma | Breast, non-Hodgkin lymphoma |
Perfluorooctanoic acid | Group 2B | Â | Testis, kidney |
Cadmium and cadmium compounds | Group 1 | Lung | Prostate, kidney |
Arsenic and inorganic arsenic compounds | Group 1 | Lung, skin, urinary bladder | Kidney, liver, prostate |
Acrylamide | Group 2A | Â | Â |